Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.
The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro.
INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Mobile Global Esports Inc. (NASDAQ: MGAM) shares gained 36.1% to $0.1565 in pre-market trading after falling around 9% on Tuesday. On April 16, Maxim Group analyst Jack Vander Aarde downgraded Mobile Global Esports from Buy to Hold.
- Chromocell Therapeutics Corporation (NYSE: CHRO) gained 29.1% to $2.35 in pre-market trading after falling around 7% on Tuesday.
- Clene Inc. (NASDAQ: CLNN) gained 27.9% to $0.3965 in pre-market trading after the company announced Phase 2 VISIONARY-MS long term extension study results at the 2024 American Academy of Neurology Annual Meeting.
- VIA optronics AG (NYSE: VIAO) shares ...